在医药产业创新中,核药成为全球战略高地,我国核药产业展现出巨大增长潜力,市场规模从2021年的30亿元增至2023年的54亿元,预计2030年将持续扩容,朝万亿级迈进。国内药企纷纷加码核药赛道,广药集团与厦门稀土所合作成立白云山稀核健康,利用自主研发的国产固体靶系统成功实现锆-89高质量制备,该系统还具备多种关键核素生产能力。广药集团制定了清晰的核药战略蓝图,包括短期突破全球瓶颈、中期建设核素生产...
Source Link在医药产业创新中,核药成为全球战略高地,我国核药产业展现出巨大增长潜力,市场规模从2021年的30亿元增至2023年的54亿元,预计2030年将持续扩容,朝万亿级迈进。国内药企纷纷加码核药赛道,广药集团与厦门稀土所合作成立白云山稀核健康,利用自主研发的国产固体靶系统成功实现锆-89高质量制备,该系统还具备多种关键核素生产能力。广药集团制定了清晰的核药战略蓝图,包括短期突破全球瓶颈、中期建设核素生产...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.